1. Home
  2. NVO vs UNH Comparison

NVO vs UNH Comparison

Compare NVO & UNH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVO
  • UNH
  • Stock Information
  • Founded
  • NVO 1923
  • UNH 1977
  • Country
  • NVO Denmark
  • UNH United States
  • Employees
  • NVO N/A
  • UNH N/A
  • Industry
  • NVO Biotechnology: Biological Products (No Diagnostic Substances)
  • UNH Medical Specialities
  • Sector
  • NVO Health Care
  • UNH Health Care
  • Exchange
  • NVO Nasdaq
  • UNH Nasdaq
  • Market Cap
  • NVO 278.0B
  • UNH 279.9B
  • IPO Year
  • NVO N/A
  • UNH 1984
  • Fundamental
  • Price
  • NVO $68.96
  • UNH $300.52
  • Analyst Decision
  • NVO Buy
  • UNH Buy
  • Analyst Count
  • NVO 3
  • UNH 25
  • Target Price
  • NVO $112.00
  • UNH $436.29
  • AVG Volume (30 Days)
  • NVO 7.7M
  • UNH 11.6M
  • Earning Date
  • NVO 08-06-2025
  • UNH 07-29-2025
  • Dividend Yield
  • NVO 1.71%
  • UNH 2.94%
  • EPS Growth
  • NVO 17.93
  • UNH 44.67
  • EPS
  • NVO 3.40
  • UNH 23.82
  • Revenue
  • NVO $43,922,211,349.00
  • UNH $410,057,000,000.00
  • Revenue This Year
  • NVO $18.59
  • UNH $13.44
  • Revenue Next Year
  • NVO $15.61
  • UNH $6.44
  • P/E Ratio
  • NVO $20.27
  • UNH $12.62
  • Revenue Growth
  • NVO 24.11
  • UNH 8.06
  • 52 Week Low
  • NVO $57.00
  • UNH $248.88
  • 52 Week High
  • NVO $143.49
  • UNH $630.73
  • Technical
  • Relative Strength Index (RSI)
  • NVO 44.64
  • UNH 42.32
  • Support Level
  • NVO $68.65
  • UNH $296.60
  • Resistance Level
  • NVO $71.75
  • UNH $304.93
  • Average True Range (ATR)
  • NVO 1.38
  • UNH 7.32
  • MACD
  • NVO -0.23
  • UNH 1.23
  • Stochastic Oscillator
  • NVO 42.83
  • UNH 13.09

About NVO Novo Nordisk A/S

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About UNH UnitedHealth Group

UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Share on Social Networks: